| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [J Periodontal Res] 2022 Jan; Vol. 57 (1), pp. 186-194. <i>Date of Electronic Publication: </i>2021 Nov 13.
- MeSH Terms: Cytokines* ; Periodontal Ligament* ; Receptors, Neurokinin-1 / *metabolism ; Receptors, Neuropeptide Y / *metabolism ; Cell Differentiation ; Cell Proliferation ; Cells, Cultured ; Gene Expression ; Humans ; Neuropeptide Y / genetics ; Osteogenesis ; Stem Cells ; Substance P
- References: Cho MI, Garant PR. Development and general structure of the periodontium. Periodontol 2000. 2000;24(1):9-27. ; Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004;364(9429):149-155. ; Isaka J, Ohazama A, Kobayashi M, et al. Participation of periodontal ligament cells with regeneration of alveolar bone. J Periodontol. 2001;72(3):314-323. ; Fawzy El-Sayed KM, Elahmady M, Adawi Z, et al. The periodontal stem/progenitor cell inflammatory-regenerative cross talk: a new perspective. J Periodontal Res. 2019;54(2):81-94. ; Winning L, El Karim IA, Lundy FT. A Comparative analysis of the osteogenic potential of dental mesenchymal stem cells. Stem Cells Dev. 2019;28(15):1050-1058. ; Racz GZ, Kadar K, Foldes A, et al. Immunomodulatory and potential therapeutic role of mesenchymal stem cells in periodontitis. J Physiol Pharmacol. 2014;65(3):327-339. ; Zhang J, Ding H, Liu X, Sheng Y, Liu X, Jiang C. Dental follicle stem cells: tissue engineering and immunomodulation. Stem Cells Dev. 2019;28(15):986-994. ; Gyorfi A, Fazekas A, Rosivall L. Neurogenic inflammation and the oral mucosa. J Clin Periodontol. 1992;19(10):731-736. ; Lundy FT, Linden GJ. Neuropeptides and neurogenic mechanisms in oral and periodontal inflammation. Crit Rev Oral Biol Med. 2004;15(2):82-98. ; Luthman J, Johansson O, Ahlstrom U, Kvint S. Immunohistochemical studies of the neurochemical markers, CGRP, enkephalin, galanin, gamma-MSH, NPY, PHI, proctolin, PTH, somatostatin, SP, VIP, tyrosine hydroxylase and neurofilament in nerves and cells of the human attached gingiva. Arch Oral Biol. 1988;33(3):149-158. ; Berkovitz B, Shellis P. Chapter 2 - Mammalian Tooth Structure and Function. In: Berkovitz B, Shellis P, eds. The teeth of mammalian vertebrates. Academic Press; 2018:25-46. ; Zhu W, Liang M. Periodontal ligament stem cells: current status, concerns, and future prospects. Stem Cells Int. 2015;2015:972313. ; Wu J, Liu S, Meng H, et al. Neuropeptide Y enhances proliferation and prevents apoptosis in rat bone marrow stromal cells in association with activation of the Wnt/beta-catenin pathway in vitro. Stem Cell Res. 2017;21:74-84. ; Lee NJ, Doyle KL, Sainsbury A, et al. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J Bone Miner Res. 2010;25(8):1736-1747. ; Movafagh S, Hobson JP, Spiegel S, Kleinman HK, Zukowska Z. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J. 2006;20(11):1924-1926. ; Teixeira L, Sousa DM, Nunes AF, Sousa MM, Herzog H, Lamghari M. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. J Cell Biochem. 2009;107(5):908-916. ; Baldock PA, Allison SJ, Lundberg P, et al. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem. 2007;282(26):19092-19102. ; Jana B, Całka J, Palus K. Inflammation changes the expression of neuropeptide Y receptors in the pig myometrium and their role in the uterine contractility. PLoS One. 2020;15(7):e0236044. ; Eapen PM, Rao CM, Nampoothiri M. Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders. Rev Neurosci. 2019;30(3):233-243. ; Divaris K, Monda KL, North KE, et al. Exploring the genetic basis of chronic periodontitis: a genome-wide association study. Hum Mol Genet. 2013;22(11):2312-2324. ; Freitag-Wolf S, Dommisch H, Graetz C, et al. Genome-wide exploration identifies sex-specific genetic effects of alleles upstream NPY to increase the risk of severe periodontitis in men. J Clin Periodontol. 2014;41(12):1115-1121. ; Lundy FT, El Karim IA, Linden GJ. Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease. Arch Oral Biol. 2009;54(3):258-262. ; Ahmed M, Srinivasan GR, Theodorsson E, Bjurholm A, Kreicbergs A. Extraction and quantitation of neuropeptides in bone by radioimmunoassay. Regul Pept. 1994;51(3):179-188. ; Linden GJ, McKinneil J, Shaw C, Lundy FT. Substance P and neurokinin A in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol. 1997;24(11):799-803. ; Lundy FT, Mullally BH, Burden DJ, Lamey PJ, Shaw C, Linden GJ. Changes in substance P and neurokinin A in gingival crevicular fluid in response to periodontal treatment. J Clin Periodontol. 2000;27(7):526-530. ; Shih C, Bernard GW. Neurogenic substance P stimulates osteogenesis in vitro. Peptides. 1997;18(2):323-326. ; Adamus MA, Dbrowski ZJ. Effect of the neuropeptide substance P on the rat bone marrow-derived osteogenic cells in vitro. J Cell Biochem. 2001;81(3):499-506. ; Azuma H, Kido JI, Ikedo D, Kataoka M, Nagata T. Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis. J Periodontol. 2004;75(7):974-981. ; Bjurholm A, Kreicbergs A, Schultzberg M, Lerner UH. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res. 1992;7(9):1011-1019. ; Somerman MJ, Archer SY, Imm GR, Foster RA. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res. 1988;67(1):66-70. ; Winning L, Robinson L, Boyd AR, El Karim IA, Lundy FT, Meenan BJ. Osteoblastic differentiation of periodontal ligament stem cells on non-stoichiometric calcium phosphate and titanium surfaces. J Biomed Mater Res A. 2017;105(6):1692-1702. ; Killough SA, Lundy FT, Irwin CR. Dental pulp fibroblasts express neuropeptide Y Y1 receptor but not neuropeptide Y. Int Endod J. 2010;43(10):835-842. ; Liu S, Wu J-Q, Hu J-J, et al. Neuropeptide Y Y1 receptor antagonist PD160170 promotes osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro and femoral defect repair in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(6):669-676. ; Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000. 1997;14(1):9-11. ; Nilsson BO. Mechanisms involved in regulation of periodontal ligament cell production of pro-inflammatory cytokines: Implications in periodontitis. J Periodontal Res. 2021;56(2):249-255. ; Ji RR, Zhang X, Wiesenfeld-Hallin Z, Hokfelt T. Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J Neurosci. 1994;14(11 Pt 1):6423-6434. ; Franquinho F, Liz MA, Nunes AF, Neto E, Lamghari M, Sousa MM. Neuropeptide Y and osteoblast differentiation - the balance between the neuro-osteogenic network and local control. FEBS J. 2010;277(18):3664-3674. ; Sousa DM, Herzog H, Lamghari M. NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target. Curr Drug Targets. 2009;10(1):9-19. ; Rosen CJ. Bone remodeling, energy metabolism, and the molecular clock. Cell Metab. 2008;7(1):7-10. ; Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cells Mater. 2012;23:13-27. ; Liu S, Jin D, Wu JQ, et al. Neuropeptide Y stimulates osteoblastic differentiation and VEGF expression of bone marrow mesenchymal stem cells related to canonical Wnt signaling activating in vitro. Neuropeptides. 2016;56:105-113. ; Gu XC, Zhang XB, Hu B, Zi Y, Li M. Neuropeptide Y accelerates post-fracture bone healing by promoting osteogenesis of mesenchymal stem cells. Neuropeptides. 2016;60:61-66. ; Zhang B, Zhang X, Xiao J, Zhou X, Chen Y, Gao C. Neuropeptide Y upregulates Runx2 and osterix and enhances osteogenesis in mouse MC3T3-E1 cells via an autocrine mechanism. Mol Med Rep. 2020;22(5):4376-4382. ; Bedoui S, Miyake S, Lin Y, et al. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol (Baltimore, Md: 1950). 2003;171(7):3451-3458. ; Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83(2):187-195. ; Zukowska Z, Grant DS, Lee EW. Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med. 2003;13(2):86-92. ; El Karim IA, Linden GJ, Orr DF, Lundy FT. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol. 2008;200(1-2):11-16. ; Fu S, Mei G, Wang Z, et al. Neuropeptide substance P improves osteoblastic and angiogenic differentiation capacity of bone marrow stem cells in vitro. Biomed Res Int. 2014;2014:10. ; Mori T, Ogata T, Okumura H, Shibata T, Nakamura Y, Kataoka K. Substance P regulates the function of rabbit cultured osteoclast; Increase of intracellular free calcium concentration and enhancement of bone resorption. Biochem Biophys Res Comm. 1999;262(2):418-422. ; Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells (Dayton, Ohio). 2010;28(4):788-798. ; Waddington RJ, Youde SJ, Lee CP, Sloan AJ. Isolation of distinct progenitor stem cell populations from dental pulp. Cells Tissues Organs. 2009;189(1-4):268-274. ; Sullivan LM, Weinberg J, Keaney JF Jr. Common statistical pitfalls in basic science research. J Am Heart Assoc. 2016;5(10):e004142. ; Widholz B, Tsitlakidis S, Reible B, Moghaddam A, Westhauser F. Pooling of patient-derived mesenchymal stromal cells reduces inter-individual confounder-associated variation without negative impact on cell viability, proliferation and osteogenic differentiation. Cells. 2019;8(6):633.
- Grant Information: British Society of Periodontology
- Contributed Indexing: Keywords: neurogenic inflammation; neuropeptide Y; osteoblastic differentiation; periodontal ligament stem cells; substance P
- Substance Nomenclature: 0 (Cytokines) ; 0 (Neuropeptide Y) ; 0 (Receptors, Neurokinin-1) ; 0 (Receptors, Neuropeptide Y) ; 0 (neuropeptide Y-Y1 receptor) ; 33507-63-0 (Substance P)
- Entry Date(s): Date Created: 20211113 Date Completed: 20220118 Latest Revision: 20220531
- Update Code: 20240513
|
